BIOMAT Database Logo BIOMAT Database Logo

Recombinant alpha 2-interferon treatment in children with chronic hepatitis B. 1988

C L Lai, and H J Lin, and P C Wu

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006521 Hepatitis, Chronic INFLAMMATION of the LIVER with ongoing hepatocellular injury for 6 months or more, characterized by NECROSIS of HEPATOCYTES and inflammatory cell (LEUKOCYTES) infiltration. Chronic hepatitis can be caused by viruses, medications, autoimmune diseases, and other unknown factors. Chronic Hepatitis,Cryptogenic Chronic Hepatitis,Hepatitis, Chronic, Cryptogenic,Hepatitis, Chronic Active,Hepatitis, Chronic Persistent,Chronic Active Hepatitis,Chronic Hepatitis, Cryptogenic,Chronic Persistent Hepatitides,Chronic Persistent Hepatitis,Hepatitis, Cryptogenic Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C L Lai, and H J Lin, and P C Wu
Recombinant alpha 2-interferon treatment in children with chronic hepatitis B.
January 1988, Lancet (London, England),
C L Lai, and H J Lin, and P C Wu
Treatment of chronic hepatitis B with recombinant interferon alpha versus recombinant interferon alpha plus levamisole.
November 1993, Journal of hepatology,
C L Lai, and H J Lin, and P C Wu
Treatment of chronic delta hepatitis with alpha-2 recombinant interferon.
January 1986, Journal of hepatology,
C L Lai, and H J Lin, and P C Wu
Prolonged interferon alpha treatment in children with chronic hepatitis B.
March 2001, Annals of tropical paediatrics,
C L Lai, and H J Lin, and P C Wu
Treatment of chronic hepatitis B in children with prednisolone withdrawal followed by recombinant interferon alpha.
August 1998, Yonsei medical journal,
C L Lai, and H J Lin, and P C Wu
Treatment with recombinant alpha 2b-interferon of chronic HDV hepatitis in children.
January 1991, Progress in clinical and biological research,
C L Lai, and H J Lin, and P C Wu
A controlled trial of recombinant interferon-alpha in Caucasian children with chronic hepatitis B.
January 1990, Digestion,
C L Lai, and H J Lin, and P C Wu
Prolonged treatment of children with chronic hepatitis B with recombinant alpha 2a-interferon: a controlled, randomized study.
March 1991, The American journal of gastroenterology,
C L Lai, and H J Lin, and P C Wu
Recombinant interferon-alpha-2A with or without steroid pretreatment in children with chronic hepatitis B.
January 1998, The Turkish journal of pediatrics,
C L Lai, and H J Lin, and P C Wu
[Prolonged (24 weeks) treatment of chronic hepatitis type B with recombinant interferon-alpha].
October 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!